Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by ...
Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...
The first patient has been enrolled in the PROSTATE-IQ trial of ArteraAI, a multimodal artificial intelligence biomarker test ...
In the study cohort, 2,310 patients died during a median follow-up of 6.3 years, and prostate cancer accounted for 454 (19.7% ...
While the majority of the literature has focused on external beam radiotherapy, the risk associated with brachytherapy appears to be somewhat less. Salvage High-Intensity Focused Ultrasound For ...
A new large-scale study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators provides the strongest ...
Fusion biopsy and patient follow-up with 3D mapping are the cornerstone of a successful Focal Therapy program. In line with ...
A shorter, higher-dose radiation treatment for prostate cancer is just as safe and effective as conventional radiotherapy, ...
A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment ...